Chronic Lymphocytic Leukemia — Trials

Chronic Lymphocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

1,256 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 265
Recruiting: 124
Ph III recruiting: 16
Growth YoY: −16.3%
Industry share: 33%
Top sponsor: City of Hope Medical Center
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (239)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01982175	Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic Leukemia(CLL004)	suspended	Phase 2	120	Shanghai Zhangjiang Biotechnology Limited CompanyINDUSTRY	1	Jun 21, 2022	clinicaltrials

Data updated 22 days agoSource updated Jun 21, 2022source: clinicaltrials